Atlas Trials

Evaluation of the Inflammation-based Index as a Predictive Marker of Clinical and Radiological Response in Patients Treated With Lu-177 Oxodotreotide for Intestinal Neuroendocrine Tumour

Clinical trial NCT06876532 · RECRUITING

Trial details

NCT number
NCT06876532
Sponsor
Institut Claudius Regaud
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Intestinal Neuroendocrine Tumor
Start date
2025-04-07
Primary completion
2029-04-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.